• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄相关性黄斑变性低光照视力障碍的特异性评估 - MACUSTAR 研究报告。

Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study report.

机构信息

Department of Ophthalmology, University Hospital Bonn, Bonn, Germany.

Department of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.

出版信息

Br J Ophthalmol. 2023 Aug;107(8):1144-1150. doi: 10.1136/bjophthalmol-2021-320848. Epub 2022 Mar 30.

DOI:10.1136/bjophthalmol-2021-320848
PMID:35354561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10359508/
Abstract

BACKGROUND/AIMS: To further validate the Vision Impairment in Low Luminance (VILL) questionnaire, which captures visual functioning and vision-related quality of life (VRQoL) under low luminance, low-contrast conditions relevant to age-related macular degeneration (AMD).

METHODS

The VILL was translated from German into English (UK), Danish, Dutch, French, Italian and Portuguese. Rasch analysis was used to assess psychometric characteristics of 716 participants (65% female, mean age 72±7 years, 82% intermediate AMD) from the baseline visit of the MACUSTAR study. In a subset of participants (n=301), test-retest reliability (intraclass correlation coefficient (ICC) and coefficient of repeatability (CoR)) and construct validity were assessed.

RESULTS

Four items were removed from the VILL with 37 items due to misfit. The resulting Vision Impairment in Low Luminance with 33 items (VILL-33) has three subscales with no disordered thresholds and no misfitting items. No differential item functioning and no multidimensionality were observed. Person reliability and person separation index were 0.91 and 3.27 for the Vision Impairment in Low Luminance Reading Subscale (VILL-R), 0.87 and 2.58 for the Vision Impairment in Low Luminance Mobility Subscale (VILL-M), and 0.78 and 1.90 for the Vision Impairment in Low Luminance Emotional Subscale (VILL-E). ICC and CoR were 0.92 and 1.9 for VILL-R, 0.93 and 1.8 for VILL-M and 0.82 and 5.0 for VILL-E. Reported VRQoL decreased with advanced AMD stage (p<0.0001) and was lower in the intermediate AMD group than in the no AMD group (p≤0.0053).

CONCLUSION

The VILL is a psychometrically sound patient-reported outcome instrument, and the results further support its reliability and validity across all AMD stages. We recommend the shortened version of the questionnaire with three subscales (VILL-33) for future use.

TRIAL REGISTRATION NUMBER

NCT03349801.

摘要

背景/目的:进一步验证 Vision Impairment in Low Luminance (VILL) 问卷,该问卷可在与年龄相关性黄斑变性(AMD)相关的低亮度、低对比度条件下捕捉视觉功能和与视觉相关的生活质量(VRQoL)。

方法

VILL 从德语翻译成英语(英国)、丹麦语、荷兰语、法语、意大利语和葡萄牙语。使用 Rasch 分析评估了 MACUSTAR 研究基线访视的 716 名参与者(65%为女性,平均年龄 72±7 岁,82%为中间型 AMD)的心理测量特征。在一组参与者(n=301)中,评估了测试-重测信度(组内相关系数(ICC)和可重复性系数(CoR))和结构效度。

结果

由于拟合不良,从 VILL 中删除了 4 个项目,剩下 37 个项目。由此产生的 Vision Impairment in Low Luminance with 33 items (VILL-33) 有三个子量表,没有无序阈值和拟合不良的项目。没有观察到差异项目功能和多维性。Vision Impairment in Low Luminance Reading Subscale (VILL-R) 的个人可靠性和个人分离指数为 0.91 和 3.27,Vision Impairment in Low Luminance Mobility Subscale (VILL-M) 为 0.87 和 2.58,Vision Impairment in Low Luminance Emotional Subscale (VILL-E) 为 0.78 和 1.90。VILL-R 的 ICC 和 CoR 为 0.92 和 1.9,VILL-M 的 ICC 和 CoR 为 0.93 和 1.8,VILL-E 的 ICC 和 CoR 为 0.82 和 5.0。报告的 VRQoL 随 AMD 晚期的进展而降低(p<0.0001),并且在中间型 AMD 组中低于无 AMD 组(p≤0.0053)。

结论

VILL 是一种具有良好心理测量特性的患者报告结局工具,其结果进一步支持其在所有 AMD 阶段的可靠性和有效性。我们建议在未来使用包含三个子量表的问卷缩短版(VILL-33)。

临床试验注册号

NCT03349801。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bed0/10359508/369efcd3fa11/bjophthalmol-2021-320848f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bed0/10359508/6f250c887fd2/bjophthalmol-2021-320848f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bed0/10359508/369efcd3fa11/bjophthalmol-2021-320848f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bed0/10359508/6f250c887fd2/bjophthalmol-2021-320848f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bed0/10359508/369efcd3fa11/bjophthalmol-2021-320848f02.jpg

相似文献

1
Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study report.年龄相关性黄斑变性低光照视力障碍的特异性评估 - MACUSTAR 研究报告。
Br J Ophthalmol. 2023 Aug;107(8):1144-1150. doi: 10.1136/bjophthalmol-2021-320848. Epub 2022 Mar 30.
2
Development of the Vision Impairment in Low Luminance Questionnaire.低亮度下视力损害问卷的编制。
Transl Vis Sci Technol. 2021 Jan 6;10(1):5. doi: 10.1167/tvst.10.1.5. eCollection 2021 Jan.
3
Development and Valuation of a Preference-Weighted Measure in Age-Related Macular Degeneration From the Vision Impairment in Low Luminance Questionnaire: A MACUSTAR Report.开发和评估源于低亮度视功能问卷的年龄相关性黄斑变性偏好加权测量法:MACUSTAR 报告。
Value Health. 2024 May;27(5):642-654. doi: 10.1016/j.jval.2024.02.001. Epub 2024 Feb 17.
4
Association of Vision-related Quality of Life with Visual Function in Age-Related Macular Degeneration.年龄相关性黄斑变性患者的视觉相关生活质量与视觉功能的相关性。
Sci Rep. 2019 Oct 25;9(1):15326. doi: 10.1038/s41598-019-51769-7.
5
Interviewer Administration Corresponds to Self-Administration of the Vision Impairment in Low Luminance (VILL) Questionnaire.访视管理对应于低亮度视力障碍(VILL)问卷的自我管理。
Transl Vis Sci Technol. 2022 Apr 1;11(4):21. doi: 10.1167/tvst.11.4.21.
6
The impact of vision impairment on vision-related quality of life of patients with neovascular age-related macular degeneration.视力损害对新生血管性年龄相关性黄斑变性患者视功能相关生活质量的影响。
Eur J Ophthalmol. 2022 Jan;32(1):481-490. doi: 10.1177/1120672120972625. Epub 2020 Nov 19.
7
Low luminance deficit and night vision symptoms in intermediate age-related macular degeneration.中度年龄相关性黄斑变性中的低亮度缺陷与夜视症状
Br J Ophthalmol. 2016 Mar;100(3):395-8. doi: 10.1136/bjophthalmol-2015-306621. Epub 2015 Aug 6.
8
Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale.使用视力损害影响量表评估年龄相关性黄斑变性患者的日常生活参与度及康复效果。
Ophthalmic Epidemiol. 2008 Mar-Apr;15(2):105-13. doi: 10.1080/09286580701840354.
9
Reliability, validity and responsiveness of the Greek MacDQoL individualized measure of the impact of macular degeneration on quality of life.希腊版黄斑变性对生活质量影响的MacDQoL个体化测量工具的信度、效度及反应度
Qual Life Res. 2017 Jan;26(1):183-191. doi: 10.1007/s11136-016-1407-2. Epub 2016 Sep 10.
10
Visual functioning and quality of life under low luminance: evaluation of the German Low Luminance Questionnaire.低亮度环境下的视觉功能和生活质量:德国低亮度问卷的评估。
Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8241-9. doi: 10.1167/iovs.11-7858.

引用本文的文献

1
Validating candidate endpoints for intermediate age-related macular degeneration trials in a multi-centre setting-lessons from the MACUSTAR study.在多中心环境中验证中度年龄相关性黄斑变性试验的候选终点——MACUSTAR研究的经验教训
Eye (Lond). 2025 Apr;39(6):1031-1039. doi: 10.1038/s41433-024-03568-2. Epub 2025 Feb 5.
2
The Spectrum of Functional, Structural, and Patient-Reported Outcomes in Intermediate Age-Related Macular Degeneration: A MACUSTAR Study Report.中年相关性黄斑变性的功能、结构及患者报告结局谱:一项MACUSTAR研究报告
Ophthalmologica. 2025;248(2):101-111. doi: 10.1159/000543231. Epub 2025 Feb 3.
3

本文引用的文献

1
Development of the Vision Impairment in Low Luminance Questionnaire.低亮度下视力损害问卷的编制。
Transl Vis Sci Technol. 2021 Jan 6;10(1):5. doi: 10.1167/tvst.10.1.5. eCollection 2021 Jan.
2
Use of Composite End Points in Early and Intermediate Age-Related Macular Degeneration Clinical Trials: State-of-the-Art and Future Directions.用于早中期年龄相关性黄斑变性临床试验的复合终点:现状与未来方向。
Ophthalmologica. 2021;244(5):387-395. doi: 10.1159/000513591. Epub 2020 Dec 7.
3
Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR.
Evaluation of the test-retest and inter-mode comparability of the Impact of Vision Impairment questionnaire in people with chronic eye diseases.
评价慢性眼病患者视力障碍问卷的重测信度和模式间可比性。
Graefes Arch Clin Exp Ophthalmol. 2024 Jun;262(6):1933-1943. doi: 10.1007/s00417-023-06334-4. Epub 2024 Jan 5.
4
Patient-reported vision impairment in low luminance predicts multiple falls.低亮度环境下患者自述的视力障碍可预测多次跌倒。
BMC Geriatr. 2023 Sep 21;23(1):583. doi: 10.1186/s12877-023-04317-y.
针对中老年黄斑变性的低干预性研究的临床研究方案,旨在为具有监管和患者准入意向的干预性临床试验开发新的临床终点 - MACUSTAR。
Trials. 2020 Jul 18;21(1):659. doi: 10.1186/s13063-020-04595-6.
4
Association of Vision-related Quality of Life with Visual Function in Age-Related Macular Degeneration.年龄相关性黄斑变性患者的视觉相关生活质量与视觉功能的相关性。
Sci Rep. 2019 Oct 25;9(1):15326. doi: 10.1038/s41598-019-51769-7.
5
Properties of the Impact of Vision Impairment and Night Vision Questionnaires Among People With Intermediate Age-Related Macular Degeneration.中度年龄相关性黄斑变性患者中视力损害和夜视问卷影响的特性
Transl Vis Sci Technol. 2019 Sep 11;8(5):3. doi: 10.1167/tvst.8.5.3. eCollection 2019 Sep.
6
Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial.亚阈值纳秒激光干预年龄相关性黄斑变性:LEAD 随机对照临床试验。
Ophthalmology. 2019 Jun;126(6):829-838. doi: 10.1016/j.ophtha.2018.09.015. Epub 2018 Sep 20.
7
MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration.MACUSTAR:中年相关性黄斑变性功能性、结构性及患者报告终点的开发与临床验证
Ophthalmologica. 2019;241(2):61-72. doi: 10.1159/000491402. Epub 2018 Aug 28.
8
Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.早期和中期干性年龄相关性黄斑变性的视觉功能指标作为临床试验终点的应用。
Am J Ophthalmol. 2018 May;189:127-138. doi: 10.1016/j.ajo.2018.02.012. Epub 2018 Mar 15.
9
Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases.美国国立眼科研究所/美国食品药品监督管理局年龄相关性黄斑变性和遗传性视网膜疾病终点研讨会报告
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3456-3463. doi: 10.1167/iovs.17-22339.
10
Development and validation of a vision and night driving questionnaire.视觉与夜间驾驶问卷的开发与验证
Ophthalmic Physiol Opt. 2016 Jul;36(4):465-76. doi: 10.1111/opo.12307.